(Q43550280)
Statements
1 reference
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study (English)
1 reference
K A Papp
1 reference
R Kaufmann
1 reference
D Thaçi
1 reference
C Hu
1 reference
D Sutherland
1 reference
P Rohane
1 reference
3 October 2012
1 reference
1 reference
27
1 reference
3
1 reference
e376-83
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference